For example, H19 has been shown to possess oncogenic properties in multiple cancers such as colorectal cancer, breast cancer and hepatocellular carcinoma, whereas in human rhabdoid cancers, H19 displays tumour-suppressive roles [57,58]. This evidence concerns the gene H19 and hepatocellular carcinoma.